Ulo, Baby Girl N.

HRN: 20-78-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2022
CEFOTAXIME 500MG (VIAL)
04/11/2022
04/17/2022
IV
52
Q8
Neonatal Sepsis
Waiting Final Action 
04/12/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2022
04/19/2022
IV
22MG
Q8
SEPCIS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: